News - Anti-virals, Rest of the World

Filter

Popular Filters

One in five South African health care centers experience ARV stock shortages

29-11-2013

South Africa’s Treatment Action Campaign (TAC) has warned that the country’s HIV treatment program…

Anti-viralsHealthcarePharmaceuticalProductionRest of the WorldSouth Africa

Deal worth $156m to provide HIV drugs for Africa

17-10-2013

The Global Fund to Fight AIDS, tuberculosis and malaria has signed a $156 million grant agreement with…

Anti-viralsHealthcarePharmaceuticalRest of the World

Campaign group's concern at blocks on India's generic exports

30-07-2013

An HIV and AIDS campaigner has written an open letter to the US government in protest at what it calls…

Anti-viralsBayerGenericsHealthcareNatco PharmaRest of the WorldSorafenib

Switzerland's Lonza involvement in South Africa pharma project in doubt

28-05-2013

The South Africa government is expected to publish a request for information from potential international,…

Anti-viralsGenericsLonzaNovartisProductionRest of the World

Mylan delivers "one pill once a day" ARV in South Africa; Cipla Debuts first Enbrel biosimilar

17-04-2013

USA-based generic drugmaker Mylan (Nasdaq: MYL) says that it has delivered, through its South African-based…

AmgenAnti-Arthritics/RheumaticsAnti-viralsAsia-PacificBiotechnologyCiplaEnbrelEtaceptGenericsMarkets & MarketingMylan LaboratoriesPfizerRest of the World

Mylan debuts HIV/AIDS drug portfolio in South Africa

24-02-2013

US generics company Mylan (Nasdaq: MYL) says that its subsidiary in South Africa has launched a comprehensive…

Anti-viralsGenericsMarkets & MarketingMylan LaboratoriesRest of the World

Indian drugmakers show interest in investing in Zimbabwe

13-09-2012

Owen Mugurungi, director of the Aids and TB Unit in Zimbabwe's Ministry of Health Child and Welfare,…

Anti-viralsAsia-PacificGenericsProductionRest of the World

Consumer groups call for fixed-dose HIV drugs in South African tenders

16-08-2012

Consumer groups Treatment Action Campaign and Medecins sans Frontiers have issued a call for the inclusion…

Anti-viralsGenericsHealthcareMarkets & MarketingPharmaceuticalPricingRest of the World

Merck & Co in-licenses Chimerix antiviral; Fiocruz to make ARVs in Africa

24-07-2012

USA-based Chimerix, a venture-funded biotech focused on developing novel oral antivirals, has announced…

Anti-viralsChimerixCMX001CMX157FiocruzGlobalLicensingMarkets & MarketingMerck & CoPharmaceuticalRest of the World

Teva gets rights to BioAlliance's Sitavig in Israel

14-06-2012

French drugmaker BioAlliance Pharma (Euronext Paris: BIO) has signed an exclusive license agreement for…

Anti-viralsBioAlliance PharmaLicensingPharmaceuticalRest of the WorldSitavigTeva Pharmaceutical Industries

Tanzanian drugmaker to start producing ARVs in August

23-05-2012

Tanzania Pharmaceutical Industries (TPI) was due to start productions earlier this year, but finalization…

Anti-viralsGenericsMarkets & MarketingPharmaceuticalRest of the WorldTanzania Pharma Industries

New pharma plant in Tanzania to produce ARVs

07-03-2012

Tanzania will start the first domestic commercial production of antiretroviral (ARV) drugs in the next…

Anti-viralsGenericsMarkets & MarketingRest of the World

New low cost HIV drug to be made by Ugandan company

09-02-2012

Starting as early as next month, Uganda will produce a new low cost and more effective life saving HIV/AIDS…

Anti-viralsGenericsMarkets & MarketingRest of the WorldTenofovir Disoproxil Fumarate

South Africa debuts new five-year HIV and tuberculosis plan

05-12-2011

Coinciding with Worlds AIDS day last week, the South African government launched its new national strategic…

Anti-viralsHealthcarePharmaceuticalRespiratory and PulmonaryRest of the World

Kenya gets $345 million from Global Fund for HIV/AIDS fight

14-11-2011

Over the next few weeks, Kenya will be signing a $345 million grant agreement with the Global Fund to…

Anti-viralsFinancialHealthcarePharmaceuticalRest of the World

ViiV Healthcare announces 16 new grantees for 2011/2012 to prevent mother-to-child HIV transmission

13-10-2011

ViiV Healthcare, the HIV/AIDS joint venture of UK drugs giant GlaxoSmithKline (LSE: GSK) and US behemoth…

Anti-viralsFinancialGlaxoSmithKlineHealthcarePfizerPharmaceuticalRest of the WorldViiV Healthcare

EU launches development and cooperation projects with South Africa, including AIDS and TB

12-09-2011

European Development Commissioner Andris Piebalgs is visiting South Africa from September 13 to 16 to…

Anti-viralsAntibiotics and Infectious diseasesEuropeFinancialHealthcarePharmaceuticalRest of the World

Sub-Saharan group says legal and policy barriers to HIV should be confronted

14-08-2011

In Sub-Saharan Africa, the region most heavily affected by HIV, legal, policy and social barriers, including…

Anti-viralsLegalPharmaceuticalPoliticsRest of the World

Back to top